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The coronavirus disease 2019 (COVID-19) vaccination frequently leads to minor side-
effects, that may be more intense after the second dose, but more serious side effects have 
been reported. We report a case of a 24-year-old man who presented to the hospital with 
acute substernal chest pain, 4 days after his second COVID-19 Moderna vaccination. 
Laboratory studies revealed elevated troponins and negative viral serologies. Cardiac 
magnetic resonance imaging (cMRI) demonstrated edema and delayed gadolinium 
enhancement of the left ventricle in a midmyocardial and epicardial distribution. The 
patient was diagnosed with myocarditis following Moderna vaccination. Our case report 
raises concern that myocarditis is a rare side effect of COVID-19 vaccine. Despite our 
report, it appears that there is a significantly higher risk of cardiac involvement from 
COVID-19 infection compared to COVID-19 vaccination. 
 
Case presentation  
 
A previously healthy 24-year-old man, with no past cardiac medical history, presented to 
emergency department with chest discomfort 4-days after his second dose of the Moderna 
COVID19 vaccine. Initially the patient experienced a subjective fevers, chills, and body 
aches in the first 24 hours after the shot. His symptoms progressed to a substernal chest 
pain, which was exacerbated with deep inspiration and supine position. The patient 
reported similar symptoms after the first vaccine administration, but these symptoms 




The patient’s electrocardiogram demonstrated a sinus rhythm without ischemic changes. 
Laboratory studies revealed: elevated troponin I (18.94ng/mL, normal 0.01- 0.04), 
elevated Creatine Kinase (704 U/L, normal 49-348), elevated C Reactive Protein (26.4 
mg/L, normal <10.0) and negative PCR for COVID-19. 
 
Viral studies, including Parvovirus B19, Ebstein-Barr virus, adenovirus, influenza, 
Herpes Simplex 1 and 2, Lyme antibody were all negative.  
 
A Transthoracic echocardiogram 4 days post vaccination was within normal limits, the 
left ventricular ejection fraction (LVEF) was 65%. No focal wall motion abnormality was 
seen.  
 
Computed tomographic angiography of the coronary arterial system 5 days post-
vaccination demonstrated a calcium score of 0 without coronary artery stenosis and small 
bilateral pleural effusions.  
 
Cardiac MRI with gadolinium 5 days post-vaccination demonstrated normal LV size and 
EF (58%), patchy mid- myocardial and epicardial delayed gadolinium enhancement 
(Fig.1), with superimposed edema (Fig.1), fulfilling the Lake Louise criteria for 
myocarditis 
 




Vaccination is a well-established part of preventive and public health medicine, but is not 
without risk. COVID-19 vaccination frequently leads to minor side-effects, for example 
pain, swelling and redness at the site of injection, and systemic symptoms of fatigue, 
headache, muscle pain, chills and fever; side effects after the second dose may be more 
intense than the first dose[1]. Among the mRNA vaccines, including Pfizer-BioNTech 
and Moderna, more serious side effects have been reported, including myocarditis[2,3]. 
Myocarditis can range from mild asymptomatic inflammation of the heart to severe heart 
failure and death[4].  
 
Viral infection has been described as one of the most common causes of myocarditis, 
especially associated with influenza and parvovirus B-19 infection. Myocarditis has been 
reported following many different vaccines, with the smallpox vaccine having the 
strongest association[5]. Due to the few cases of myocarditis reported post COVID-19 
vaccine, little is known about this process.  
 
The Israeli Ministry of Health reported 62 cases of myocarditis in patients vaccinated for 
COVID-19 out of 5 million vaccinated individuals. Most cases occurred after the second 
dose of mRNA vaccines, with only 6 cases diagnosed after the first dose. The prevalence 
was higher in men under 30 years of age, increasing from 1/100 000 for the general 
population, to 1/20 000 for the 16-30 years old group. Two of the 62 patients died. The 
U.S. Department of Defense reported 14 military personnel diagnosed with myocarditis 
following COVID vaccination, 13 of them after their second dose of COVID-19 mRNA 
vaccines. Three of the personnel received Pfizer/BioNTech vaccine, and 11 had received 
the Moderna vaccine, with an occurrence of 0.52/100 000 among the 2.7 million military 
personnel vaccinated[2,3].  
 
At time of writing, neither the FDA nor CDC have reported any safety signals for 
myocarditis following the administration of the approved COVID-19 vaccines[6]. At 
present time, there are no reports in the scientific literature reporting notion of 
myocarditis related to COVID-19 vaccination. 
 
There are specific indications for cardiac MRI in suspected myocarditis case including 
currently symptomatic cases, evidence of myocardial damage and suspected viral or 
autoimmune etiologies[7,8]. The diagnosis of myocarditis can be confirmed by cardiac 
MRI. Two criteria have been developed – the Original and the 2018 Lake Louise Criteria 
for the diagnosis of acute myocarditis. In the original criteria, two out of three elements 
are needed for diagnosis. The three elements are: (1) regional or global myocardial signal 
intensity increase on T2-weighted images; (2) increased global myocardial early 
gadolinium enhancement ratio; (3) at least one focal, nonischemic lesion at late 
gadolinium enhancement. In the revised 2018 Lake Louise criteria, both (1) regional or 
global myocardial signal intensity and relaxation time increase on T2-weighted images 
and (2) increase native relaxation time and extracellular volume on T1-weighted images 
and nonischemic pattern late gadolinium enhancement are needed[7,8]. 
         
 
In summary, we recognize that vaccination is one of the greatest advancement in 
medicine in the previous century, and has significantly reduced the burden of infectious 
disease[9]. From Louis Pasteur, who developed the first laboratory vaccine in 1879, for 
chicken cholera[10], to the 21st century COVID-19 pandemic, untold disability and death 
has been prevented by vaccination[9]. Despite the demonstration of safety, and the 
endorsement of the World Health Organization, and other bodies that vaccines are far 
safer than therapeutic drugs, vaccines are not without risk[9]. Myocarditis is one of the 
serious adverse event of vaccination[5].  
 
We believe that given the negative PCR test for COVID-19, as well as the negative viral 
serologies, myocarditis, in this instance, was due to the vaccine, rather than acute 
infection, but the latter possibility cannot be totally discounted. The mechanisms 
involved in such vaccine-related myocarditis are not clear as of this writing[11].  
 
The patient has been discharged from hospital with beta-blocker medication. He was 
instructed to avoid strenuous activities for three months, as well as non-steroidal anti-
inflammatory drugs (NSAID). The patient has a scheduled follow-up appointment with 




Despite the fact that myocarditis has been reported following many vaccines[5], further 
research will be needed to confirm the association of myocarditis post-COVID-19 
vaccination. The data in hand suggest a small risk of myocarditis following infection 
[7,8,12], as well as thrombosis related myocardial infarction [13]. Thus despite our 
report, it appears that there is a significantly higher risk of cardiac involvement from 
COVID-19 infection compared to COVID-19 vaccination[12]. Accordingly, we believe 







Written, informed consent for publication of his case was obtained from the patient. 















































E.                                 F. 
 
Fig. 1. A and B: Short axis T2 images of the mid left ventricle showing hyperintense 
signal of the antero-lateral and infero-lateral segments. C and D: Short axis 10 minutes 
post-gadolinium injection of the mid left ventricle showing mid myocardial and 
epicardial enhancement in the same distribution. E : 4 chambers view T2 images showing 
hyperintense signal of the lateral wall of the left ventricle. F: 4 chambers view 10 minutes 
post-gadolinium injection showing enhancement in the same distribution. 
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